NYLIM
CERE

New York Life Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

New York Life Investment Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-178,765
Closed -$7.31M – 886
2024
Q2 		$7.31M Buy
178,765
+32,923
+23% +$1.35M 0.07% 243
2024
Q1 		$6.16M Buy
+145,842
New +$6.16M 0.06% 281